cAMP Gs dynamic kit
Optimal performance when applied to Gs activation or inhibition
-->
The total AP2 kit enables the cell-based quantitative detection of AP2, for monitoring GPCR activity.
The Total AP2 cellular assay monitors total AP2 beta, and is used to detect the expression of endogenous or overexpressed AP2 beta in various cells. AP2 beta are components of the adaptor protein complex 2 (AP-2) and are known to function as cargo proteins. They play several roles in cells, including the internalization of GPCRs through a clathrin-dependent endocytosis process by direct interaction with beta arrestins. Variations of AP2 beta expression cause specific dampening of cellular responses to stimuli such as hormones, neurotransmitters, or sensory signals. As AP2 is expressed in various tissues, it is believed that AP2 may play a major role in many cancers or other human diseases (diabetes...) by regulating receptor-mediated functions.
The Total AP2 assay quantifies the expression level of AP2 beta in a cell lysate. Unlike Western Blot, the assay is entirely plate-based, and does not require gels, electrophoresis, or transfer. The Total AP2 assay uses two labeled antibodies, one coupled to a donor fluorophore and the other to an acceptor. Both antibodies are highly specific for a distinct epitope on the protein. In presence of AP2 in a cell extract, the addition of these conjugates brings the donor fluorophore into close proximity with the acceptor, and thereby generates a FRET signal. Its intensity is directly proportional to the concentration of the protein present in the sample, and provides a means of assessing the protein’s expression under a no-wash assay format.
Detection of total AP2 with HTRF reagents can be performed in a single plate used for culturing, stimulation, and lysis. No washing steps are required. This HTS designed protocol enables miniaturization while maintaining robust HTRF quality.
Detection of total AP2 with HTRF reagents can be performed in a single plate used for culturing, stimulation, and lysis. No washing steps are required. This HTS designed protocol enables miniaturization while maintaining robust HTRF quality.
HEK293 cells were cultured in a T175 flask in complete culture medium at 37°C, 5% CO2. After 72h incubation, the cells were lysed with 3 mL of lysis buffer #4 (1X) for 30 minutes at RT under gentle shaking.
Serial dilutions of the cell lysate were performed using lysis buffer, and 13 µL of each dilution were transferred into a low volume white microplate before the addition of 3µL Lysis buffer + 4 µL of HTRF Total-AP2 detection reagents. Equal amounts of lysates were used for a side by side comparison between HTRF and Western Blot.
The side by side comparison of Western Blot and HTRF demonstrates that the HTRF assay is 16-fold more sensitive than the Western Blot, at least under these experimental conditions.
Human (HEK293), Hamster (CHO-K1), and murine (NIH3T3) cells were plated at 100,000 cells/ well in a 96 well plate in cell culture medium, and incubated for 24h at 37°C, 5% CO2. Medium was then removed, and cells were lysed with 50 µL of lysis buffer for 30min at RT under gentle shaking. 16 µL of lysate were transferred into a 384-well sv white microplate, and 4 µL of the HTRF Total AP2 detection reagents were added. The HTRF signal was recorded after 3h incubation at room temperature.
Expression levels correlate well with data from the literature and with qPCR experiments performed with the same cells as the HTRF assays.
B-arrestins play central roles in the GPCR signaling pathways by regulating agonist-mediated GPCR signaling. Among B-arrestin implications, they mediate both receptor desensitization and resensitization processes, act as a signaling scaffold for MAPK pathways, such as MAPK1/3 or AKT1, and participate in the recruitment of the ubiquitin-protein ligase to the receptors. Beta-arrestins function as multivalent adapter proteins that can switch the GPCR from a G-protein signaling mode (that transmits short-lived signals from the plasma membrane) to a beta-arrestin signaling mode that transmits a distinct set of signals initiated as the receptor internalizes and transits the intracellular compartment.
During the GPCR desensitization process, B-arrestins bind to the GRK-phosphorylated receptor, and sterically preclude its coupling to the G-protein.
B-arrestins target many receptors for internalization in clathrin-coated pits by interacting with the β-adaptin subunit of the AP2 complex, and so recruit the GPCRs into a multipartite complex. The interaction between B-arrestin and AP2 is the central initial step in localizing the GPCRs into the clathrin-coated pits following agonist stimulation, and so pharmacological compounds targeting this interaction are of considerable interest.
Internalized arrestin-receptor complexes traffic to intracellular endosomes.
Receptor resensitization then requires receptor-bound arrestin to be removed, so that the receptor can be dephosphorylated and returned to the plasma membrane. The extent of beta-arrestin involvement appears to vary significantly depending on the receptor, agonist, and cell type.
GPCR in Cardiovascular Research: The Relevance of Camp and IP-1 Second Messenger Assays
See how peer researchers monitor GPCR signaling with HTRF - Application Notes
Product Insert AP2 / 64AP2TPEB-64AP2TPEC
64AP2TPEB-64AP2TPEC - Product Insert
GTP binding assay : Gαi agonist and antagonist guides
Discover how to get the most out of your Gαi agonist and antagonist research with our HTRF GTP binding assays. - Guides
A new specific kit for characterizing compounds inducing B-arrestin2 recruitment at GPCR
Discover how the β-arr2 recruitment kit can help you study the interaction between AP-2 and β-arrestin2. - Application Notes
GPCR compounds identification and pharmacological characterization with GTP Gi binding assay
Characterization of candidate molecules through GTP binding assays - Application Notes
eBook | Exploring β-Arrestins and Their Therapeutic Potential
Deepen Your β-Arrestin Knowledge - Guides
GPCRs: the pathway to Discovery
Complete solutions for GPCR Drug Discovery - Brochures
Safety Data Sheet (DEU) AP2 / 64AP2TPEB
64AP2TPEB - Safety Data Sheet
Safety Data Sheet (ELL) AP2 / 64AP2TPEB
64AP2TPEB - Safety Data Sheet
Safety Data Sheet (FRA-FR) AP2 / 64AP2TPEB
64AP2TPEB - Safety Data Sheet
Safety Data Sheet (ITA) AP2 / 64AP2TPEB
64AP2TPEB - Safety Data Sheet
Safety Data Sheet (SPA) AP2 / 64AP2TPEB
64AP2TPEB - Safety Data Sheet
Safety Data Sheet (ENG-GB) AP2 / 64AP2TPEB
64AP2TPEB - Safety Data Sheet
Safety Data Sheet (ENG-US) AP2 / 64AP2TPEB
64AP2TPEB - Safety Data Sheet
Safety Data Sheet (DEU) AP2 / 64AP2TPEC
64AP2TPEC - Safety Data Sheet
Safety Data Sheet (ELL) AP2 / 64AP2TPEC
64AP2TPEC - Safety Data Sheet
Safety Data Sheet (FRA-FR) AP2 / 64AP2TPEC
64AP2TPEC - Safety Data Sheet
Safety Data Sheet (ITA) AP2 / 64AP2TPEC
64AP2TPEC - Safety Data Sheet
Safety Data Sheet (SPA) AP2 / 64AP2TPEC
64AP2TPEC - Safety Data Sheet
Safety Data Sheet (ENG-GB) AP2 / 64AP2TPEC
64AP2TPEC - Safety Data Sheet
Safety Data Sheet (ENG-US) AP2 / 64AP2TPEC
64AP2TPEC - Safety Data Sheet
Choosing the right microplate reader ensures you’ll get an optimal readout. Discover our high performance reader, or verify if your lab equipment is going to be compatible with this detection technology.
Let's find your readerYou might be interested in